Minireview: MIRomics in Endocrinology: A Novel Approach for Modeling Endocrine Diseases

by Szabó, Péter M., Butz, Henriett, Igaz, Péter, Rácz, Károly, Hunyady, László, Patócs, Attila
Published in Mol Endocrinol (2013)

miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1

by Butz, Henriett, Szabó, Peter M., Khella, Heba W.Z., Nofech-Mozes, Roy, Patocs, Attila, Yousef, George M.
Published in Oncotarget (2015)

Integrative analysis of neuroblastoma and pheochromocytoma genomics data

by Szabó, Peter M, Pintér, Miklós, Szabó, Diana Rita, Zsippai, Adrienn, Patócs, Attila, Falus, András, Rácz, Károly, Igaz, Peter
Published 2012

mRNA and microRNA expression patterns in adrenocortical cancer

by Zsippai, Adrienn, Szabó, Diana Rita, Szabó, Peter M, Tömböl, Zsófia, Bendes, Melinda R, Nagy, Zoltán, Rácz, Károly, Igaz, Peter
Published 2011

Nivolumab in Patients with Advanced Platinum-Resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275

by Galsky, Matthew D., Saci, Abdel, Szabo, Peter M., Han, G. Celine, Grossfeld, Gary, Collette, Sandra, Siefker-Radtke, Arlene, Necchi, Andrea, Sharma, Padmanee
Published in Clin Cancer Res (2020)

Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC

by Ross-Macdonald, Petra, Walsh, Alice M, Chasalow, Scott D, Ammar, Ron, Papillon-Cavanagh, Simon, Szabo, Peter M, Choueiri, Toni K, Sznol, Mario, Wind-Rotolo, Megan
Published in J Immunother Cancer (2021)

Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapies

by Módos, Dezső, Bulusu, Krishna C., Fazekas, Dávid, Kubisch, János, Brooks, Johanne, Marczell, István, Szabó, Péter M., Vellai, Tibor, Csermely, Péter, Lenti, Katalin, Bender, Andreas, Korcsmáros, Tamás
Published in NPJ Syst Biol Appl (2017)

Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer

by Wang, Li, Gong, Yixuan, Saci, Abdel, Szabo, Peter M., Martini, Alberto, Necchi, Andrea, Siefker-Radtke, Arlene, Pal, Sumanta, Plimack, Elizabeth R., Sfakianos, John P., Bhardwaj, Nina, Horowitz, Amir, Farkas, Adam M., Mulholland, David, Fischer, Bruce S., Oh, William K., Sharma, Padmanee, Zhu, Jun, Galsky, Matthew D.
Published in Eur Urol (2019)

Multiple SARS-CoV-2 Introductions Shaped the Early Outbreak in Central Eastern Europe: Comparing Hungarian Data to a Worldwide Sequence Data-Matrix

by Kemenesi, Gábor, Zeghbib, Safia, Somogyi, Balázs A, Tóth, Gábor Endre, Bányai, Krisztián, Solymosi, Norbert, Szabo, Peter M, Szabó, István, Bálint, Ádám, Urbán, Péter, Herczeg, Róbert, Gyenesei, Attila, Nagy, Ágnes, Pereszlényi, Csaba István, Babinszky, Gergely Csaba, Dudás, Gábor, Terhes, Gabriella, Zöldi, Viktor, Lovas, Róbert, Tenczer, Szabolcs, Kornya, László, Jakab, Ferenc
Published in Viruses (2020)

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

by Wang, Li, Saci, Abdel, Szabo, Peter M., Chasalow, Scott D., Castillo-Martin, Mireia, Domingo-Domenech, Josep, Siefker-Radtke, Arlene, Sharma, Padmanee, Sfakianos, John P., Gong, Yixuan, Dominguez-Andres, Ana, Oh, William K., Mulholland, David, Azrilevich, Alex, Hu, Liangyuan, Cordon-Cardo, Carlos, Salmon, Hélène, Bhardwaj, Nina, Zhu, Jun, Galsky, Matthew D.
Published in Nat Commun (2018)

Randomized trial of oral cyclophosphamide and veliparib in high-grade serous ovarian, primary peritoneal, or fallopian tube cancers, or BRCA-mutant ovarian cancer

by Kummar, Shivaani, Oza, Amit M., Fleming, Gini F., Sullivan, Daniel M., Gandara, David R., Naughton, Michael J., Villalona-Calero, Miguel A., Morgan, Robert J., Szabo, Peter M., Youn, Ahrim, Chen, Alice P., Ji, Jiuping, Allen, Deborah E., Lih, Chih-Jian, Mehaffey, Michele G., Walsh, William D., McGregor, Paul M., Steinberg, Seth M., Williams, Paul M., Kinders, Robert J., Conley, Barbara A., Simon, Richard M., Doroshow, James H.
Published in Clin Cancer Res (2015)

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

by Skoulidis, Ferdinandos, Goldberg, Michael E., Greenawalt, Danielle M., Hellmann, Matthew D., Awad, Mark M., Gainor, Justin F., Schrock, Alexa B., Hartmaier, Ryan J., Trabucco, Sally E., Gay, Laurie, Ali, Siraj M., Elvin, Julia A., Singal, Gaurav, Ross, Jeffrey S., Fabrizio, David, Szabo, Peter M., Chang, Han, Sasson, Ariella, Srinivasan, Sujaya, Kirov, Stefan, Szustakowski, Joseph, Vitazka, Patrik, Edwards, Robin, Bufill, Jose A., Sharma, Neelesh, Ou, Sai-Hong I., Peled, Nir, Spigel, David R., Rizvi, Hira, Aguilar, Elizabeth Jimenez, Carter, Brett W., Erasmus, Jeremy, Halpenny, Darragh F., Plodkowski, Andrew J., Long, Niamh M., Nishino, Mizuki, Denning, Warren L., Galan-Cobo, Ana, Hamdi, Haifa, Hirz, Taghreed, Tong, Pan, Wang, Jing, Rodriguez-Canales, Jaime, Villalobos, Pamela A., Parra, Edwin R., Kalhor, Neda, Sholl, Lynette M., Sauter, Jennifer L., Jungbluth, Achim A., Mino-Kenudson, Mari, Azimi, Roxana, Elamin, Yasir Y., Zhang, Jianjun, Leonardi, Giulia C., Jiang, Fei, Wong, Kwok-Kin, Lee, J. Jack, Papadimitrakopoulou, Vassiliki A., Wistuba, Ignacio I., Miller, Vincent A., Frampton, Garrett M., Wolchok, Jedd D., Shaw, Alice T., Jänne, Pasi A., Stephens, Philip J., Rudin, Charles M., Geese, William J., Albacker, Lee A., Heymach, John V.
Published in Cancer Discov (2018)